TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/14/23 17:00 | 3/10/23 | ZYME | Zymeworks Inc. | DE | Health | Drug | Pharmaceutical Preparations | Klompas Neil A | DE | O | P,COO | S.d | -23 | 7.83 | 0 | -3 | -14 | 18 | D | ||||||||||||||
3/11/22 21:00 | 3/10/22 | ZYME | Zymeworks Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Klompas Neil A | A1 | O | COO | S.d | -20 | 6.88 | 0 | -3 | -18 | 14 | D | ||||||||||||||
3/12/21 20:00 | 3/10/21 | ZYME | Zymeworks Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Klompas Neil A | A1 | O | CFO | S.d | -50 | 34.95 | 0 | -1 | -11 | 11 | D | ||||||||||||||
1/11/21 21:42 | 12/9/20 | ZYME | Zymeworks Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Klompas Neil A | A1 | O | CFO | S.a | -1,331 | 53.25 | 0 | -25 | -73 | 9 | D | ||||||||||||||
12/11/20 19:30 | 12/9/20 | ZYME | Zymeworks Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Klompas Neil A | A1 | O | CFO | S.d | -1,331 | 53.25 | 0 | -25 | -72 | 10 | D | ||||||||||||||
5/8/19 16:27 | 5/6/19 | ZYME | Zymeworks Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Klompas Neil A | A1 | O | CFO | S.d | -160 | 19.23 | 0 | -8 | -49 | 9 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |